First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists

By sjmartinez • April 18, 2023

Hanna C, Pettersen K, Pedley N. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med. 2023 Apr;176(4):eL230006. doi: 10.7326/L23-0006. PMID: 37068293.

Tags: General Internal Medicine, Olive View DoM, Publications

Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for Quality Improvement

Quigley DD, Predmore Z, Panayotou MS, Elliott MN, Hays RD. Feasibility of Using Clinicians to Code the Actionability of Narrative Comments About Patient Experience for[...]

Mechanisms of Benefit in Geriatric Assessment (GA): Approach-Oriented Coping Mediates Outcomes of a GA-Guided Supportive Care Intervention (GAIN-S)

Bergerot CD, Bergerot PG, Razavi M, França MVDS, Cerveira JA, Fuzita WH, Philip EJ, Ferreira CGM, Buso MM, Nipp R, El-Jawahri A, Soto-Perez-de-Celis E, Dale[...]

A Cluster Randomized Controlled Trial to Improve Influenza and Tdap Vaccination Rates for Pregnant Women

Rand CM, Bender R, Albertin C, Schrader ARB, Humiston SG, Olson-Chen C, Westen EA, Chen J, Hsu YJ, Parker Fiebelkorn A, Vangala S, Szilagyi PG.[...]